Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Prospective Study of Scheduled Intravenous Ramosetron for the Prevention of Nausea and Vomiting in Hospitalized Patients After Gynecologic Laparoscopy

NCT02011659 is registered in ClinicalTrials.gov with National Health Insurance Service Ilsan Hospital as lead sponsor.

NCT NCT02011659
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02011659 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Prospective Study of Scheduled Intravenous Ramosetron for the Prevention of Nausea and Vomiting in Hospitalized Patients After Gynecologic Laparoscopy
Lead sponsor
National Health Insurance Service Ilsan Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
November 30, 2013
Completion date
Not reported
Enrollment
128 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

uterine myoma, ovary neoplasm, adenomyosis